Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,039 | 5,197 | 4,961 | 5,600 | 5,673 | 5,768 | 5,667 | 6,268 | 7,048 | 7,168 | 7,475 | 8,277 | |
| COGS | 1,703 | 1,726 | 1,574 | 1,745 | 1,690 | 1,722 | 1,686 | 1,772 | 1,825 | 1,878 | 1,852 | 2,089 |
| Gross profit | 3,336 | 3,471 | 3,387 | 3,856 | 3,983 | 4,046 | 3,981 | 4,496 | 5,223 | 5,289 | 5,623 | 6,188 |
| 2,418 | 2,433 | 2,390 | 2,615 | 2,642 | 2,690 | 2,660 | 2,769 | 2,881 | 3,028 | 3,137 | 3,738 | |
| 918 | 1,038 | 997 | 1,241 | 1,340 | 1,356 | 1,321 | 1,727 | 2,341 | 2,262 | 2,486 | 2,450 | |
| OPM % | 18.2% | 20% | 20.1% | 22.2% | 23.6% | 23.5% | 23.3% | 27.6% | 33.2% | 31.6% | 33.3% | 29.6% |
| Depreciation | 248 | 257 | 457 | 248 | 257 | 271 | 393 | 299 | 317 | 313 | 447 | 453 |
| Interest | 81 | 74 | 71 | 68 | 71 | 67 | 89 | 92 | 108 | 115 | 120 | 110 |
| 40 | 29 | 29 | 68 | 42 | 54 | 57 | 79 | 90 | -312 | 9 | 130 | |
| Profit before tax | 630 | 736 | 498 | 993 | 1,055 | 1,071 | 896 | 1,416 | 2,007 | 1,522 | 1,928 | 2,017 |
| Tax | 134 | 117 | 129 | 187 | 195 | 212 | 113 | 194 | 522 | 342 | 459 | 600 |
| Tax % | 21.3% | 16% | 26% | 18.9% | 18.5% | 19.8% | 12.7% | 13.7% | 26% | 22.4% | 23.8% | 29.8% |
| 495 | 619 | 368 | 806 | 859 | 859 | 782 | 1,221 | 1,485 | 1,181 | 1,469 | 1,417 | |
| PAT margin % | 9.8% | 11.9% | 7.4% | 14.4% | 15.2% | 14.9% | 13.8% | 19.5% | 21.1% | 16.5% | 19.7% | 17.1% |
| EPS (₹) | 10.8 | 13.5 | 7.9 | 17.6 | 18.7 | 18.8 | 16.9 | 26.7 | 32.4 | 25.7 | 32 | 31 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +21.5% | +20.2% | +12% | +16.3% | +12.6% | +11% | +14.2% | +11.9% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Pharmaceuticals | 8,234.35 | 2,060.58 | 40,603.3 | 16,738.41 | 23,864.89 |
| Others | 43.03 | -43.2 | 235.46 | 119.48 | 115.98 |
| +24.2% |
| +24.3% |
| +31.9% |
| +32% |
| PAT YoY % | +268.3% | +292.5% | +51.9% | +77.7% | +73.5% | +38.8% | +112.5% | +51.6% | +72.8% | +37.5% | +87.7% | +16% |
| Less: Inter segment | 0 | 0 | -21.65 | -21.66 | — |
₹ crore by quarter